Sign in

NCT07599696Recruiting

Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements

Speech Amplification Devices for Parkinson and Related Diseases: Talker- and Technology-Driven Enhancements

Source: ClinicalTrials.gov · Last updated 20 May 2026

Brief summary (registry, in English)

The proposed research aims to investigate the use of speech amplification devices as a potential treatment option for people with Parkinson's disease and related disorders who exhibit hypophonia, a voice disorder that affects over half of those with Parkinson's disease. By characterizing the acoustic and perceptual effects of speech amplification and identifying ways to optimize outcomes through talker- and device-specific enhancements, this project seeks to develop personalized, evidence-based treatment options for hypophonia. The current proposal will move this effort forward by systematically eliciting and modifying speech amplification device output that leverage both behavioral and technological approaches.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
5 May 2026
Start date
1 Mar 2024
Primary completion date
31 Dec 2027
Lead sponsor
Michigan State University
NCT number
NCT07599696

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 1 Mar 2024 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Uncorrected hearing loss that exceeds a threshold of 40 dB HL in more than one ear (as per baseline screening audiometry) and/or use of a cochlear implant.

Other illness

  • History of any other speech, language, or neurological concern other than Parkinson/parkinsonism.

Who the study is looking for

  • Dominant speakers of North American English
  • Have received a neurologist's diagnosis of Parkinson disease or parkinsonism (e.g., PSP/MSA/PSP)
  • Present with changes in their speech/voice

Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Michigan State University
Coordinator of this site? Confirm its status
East LansingUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.